CANY
EW icon

Caxton Associates (New York)’s Edwards Lifesciences EW Stock Holding History

Caxton Associates (New York)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,100
Closed -$2.75M – 487
2023
Q4 		$2.75M Hold
36,100
– – 0.14% 86
2023
Q3 		$2.5M Buy
36,100
+23,203
+180% +$1.86M 0.34% 54
2023
Q2 		$1.22M Sell
12,897
-4,014
-24% -$349K 0.18% 123
2023
Q1 		$1.4M Sell
16,911
-5,489
-25% -$431K 0.21% 95
2022
Q4 		$1.67M Buy
22,400
+5,005
+29% +$386K 0.11% 60
2022
Q3 		$1.44M Buy
+17,395
New +$1.67M 0.19% 54
2021
Q4 		– Sell
-3,604
Closed -$408K – 591
2021
Q3 		$408K Sell
3,604
-614
-15% -$70.1K 0.05% 245
2021
Q2 		$437K Buy
+4,218
New +$398K 0.05% 207
2020
Q4 		– Sell
-4,664
Closed -$372K – 196
2020
Q3 		$372K Buy
+4,664
New +$364K 0.04% 158
2020
Q2 		– Sell
-9,807
Closed -$617K – 511
2020
Q1 		$617K Buy
9,807
+2,799
+40% +$202K 0.11% 119
2019
Q4 		$545K Buy
+7,008
New +$547K 0.07% 161
2019
Q1 		– Sell
-5,145
Closed -$263K – 413
2018
Q4 		$263K Sell
5,145
-5,394
-51% -$273K 0.04% 204
2018
Q3 		$612K Hold
10,539
– – 0.04% 201
2018
Q2 		$511K Buy
10,539
+726
+7% +$33.9K 0.03% 238
2018
Q1 		$456K Buy
+9,813
New +$426K 0.02% 269

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Caxton Associates (New York)'s EW Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 36,100 shares — an estimated $2.75M sold.

Caxton Associates (New York) first reported a position in EW in Q1 2018 and held it in 15 quarters. The position peaked at $2.75M in Q4 2023. 1,282 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Caxton Associates (New York) reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 36,100 Edwards Lifesciences shares in Q1 2024, an estimated $2.75M.
  • Caxton Associates (New York) first reported a position in Edwards Lifesciences in Q1 2018 and held it in 15 quarters.
  • Caxton Associates (New York)'s Edwards Lifesciences position peaked at $2.75M in Q4 2023.
  • 1,282 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.